Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028

Donia, M.; Jespersen, H.; Jalving, M.; Lee, R.; Eriksson, H.; Hoeller, C.; Hernberg, M.; Gavrilova, I.; Kandolf, L.; Liszkay, G.; Helgadottir, H.; Zhukavets, A.; Pianova, D.; Marquez-Rodas, I.; Neyns, B.; Westgeest, H.; Pourmir, I.; Sobczuk, P.; Ellebaek, E.; Amaral, T.

Publication services
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
View Item

« back

Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028

Author:

Donia, M.; Jespersen, H.; Jalving, M.; Lee, R.; Eriksson, H.; Hoeller, C.; Hernberg, M.; Gavrilova, I.; Kandolf, L.; Liszkay, G.; Helgadottir, H.; Zhukavets, A.; Pianova, D.; Marquez-Rodas, I.; Neyns, B.; Westgeest, H.; Pourmir, I.; Sobczuk, P.; Ellebaek, E.; Amaral, T.

Tübinger Autor(en):

Amaral, Teresa

Published in:

Esmo Open (2025), Bd. 10 (3), Article 104295

Verlagsangabe:

Amsterdam : Elsevier

Language:

English

Full text:

http://dx.doi.org/10.1016/j.esmoop.2025.104295

ISSN:

2059-7029